Industry Sector

MedTech & Diagnostics

LSC helps medical device, diagnostic, and connected healthcare companies to accelerate growth by valuing new opportunities, increasing access to patients and launching advanced technology-enabled products across the patient journey.

Our medical device category coverage includes:

Disease/Therapeutic Areas


Corporate solutions

Developing product strategy and launch plans

  • Behavioral drivers and decision-making among stakeholders
  • Clinical use case and business case validation
  • Market and product forecasting
  • Marketing campaign and message testing
  • Next generation product strategy
  • Overcoming barriers to adoption
  • Patient journey mapping
  • Pricing model and price strategy
  • Product profile development
  • Referral pathway mapping
  • Segmentation and targeting

Accelerating growth

  • Business case development
  • Channel and partnering assessment and strategy
  • Competitor landscape analysis
  • New and/or adjacent market opportunity assessment
  • New market entry strategy and planning
  • Portfolio strategy and management
  • Strategic partnerships assessment

Improving profitability

  • Bottom-up revenue forecasting and financial modeling
  • Commercial model benchmarking
  • Payor coverage strategy
  • Pricing model and strategy
  • Sales and marketing functional and organizational design

Expanding access and improving health equity

  • Behavioral drivers and decision-making in healthcare ecosystems
  • Channel strategy and operational model design
  • Market and financial modeling and forecasting
  • Patient availability and drop-off assessment
  • Patient data and money flow analysis
Logo LSC



The LSC MedTech team uses proven qualitative and quantitative methodologies that include global In-house primary and secondary market research and insights research with a range of clinical and non-clinical stakeholders including referrer, product user/healthcare provider, hospital admin, extenders, patients, caregivers.


HCPs that LSC has worked extensively with cardiac surgeons, interventional cardiologists, general and specialty surgeons, ophthalmologists, intensivists, neurologists, neurosurgeons, gastroenterologists, urologists, urogynecologist, radiologists, interventional radiologists, vascular surgeons, electrophysiologists, orthopedic surgeons, trauma specialists, nerve repair specialists, oncologists, pulmonologist, nephrologists, hepatologist, and more.


Having conducted 1000+ market insight and growth strategy projects, the LSC team will recommend a customized approach based on each clint’s unique project needs.

Success Stories

Identified and evaluated Next Generation sensor/wearable technologies ​

Provided transaction advisory for potential acquisition of new therapy treatment technology for global MedTech company​

Due diligence of early-stage cardiovascular technology for MedTech venture capital company​

Supported marketing team in global launch and pricing of new generation cardiovascular device  ​

Designed a cardiovascular risk management program for private insurers in Mexico

Development of GTM model for a non-invasive diagnostic liver disease test


Industry Leaders

Partner, MedTech Practice

Dean GrayBOSTON, MA.

Dean Gray has over 30 years of experience in life sciences and healthcare, having held senior consulting roles and many industry roles in strategy and operations. He has guided large firms and startups to bring transformative MedTech, BioPharma and Digital Health products to market, at pace.

Dean provides growth strategy and commercial expertise that has accelerated business growth for clients in the U.S., Europe, and Asia across a broad range of diagnostic and therapeutic applications. He has deep knowledge of customer and patient-centric device-data solutions, digital biomarkers and therapeutics, remote monitoring and mobile health, diagnostic imaging, robotics, and AI-enabled platforms particularly in ophthalmology, orthopedics, gastroenterology, urology, cell therapy and regenerative medicine, neurodegenerative and metabolic diseases, and a range of surgical specialties. Dean excels at helping clients to understand new growth opportunities, develop actionable growth and go-to-market strategies supported with compelling clinical and business cases, prepare and implement impactful product launches, and rapidly and profitably scale. Prior to joining LSC, Dean was a partner and global lead for digital surgery at PA Consulting. Before that, he was a partner at Technology Commercialization Group and a principal at Appareo, both life science strategy consultancies. Dean spent 20 years in the life sciences industry, including as VP/GM of Heidelberg Engineering’s neurology division, VP of global marketing for bio-orthopedics at Sanofi Genzyme, and as VP international marketing and VP strategic planning for Boston Scientific’s endoscopy and urology divisions. Earlier, Dean was GM of the surgical skin preparation business unit at BD and regional business manager for Asia at Lederle (now Pfizer).

He holds a master’s degree in international business from Columbia University and a bachelor’s degree from Earlham College.

Partner, MedTech Practice


Sabeen Shaikh is a global healthcare executive with nearly 20 years of experience in the medical technology industry with focus in medical hardware and software devices, digital health and AI/ML technologies.  She has held a number of commercial and operational leadership roles on both the corporate industry and innovation side, bridging the gap between the two worlds for relevant stakeholders in the ecosystem. 

Sabeen’s strategic expertise is focused in executive leadership with change management, corporate and commercial strategies, commercial and vendor due diligences, market access planning, roadmap planning and prioritization, new business models and exit strategies.  Sabeen’s domain expertise is focused in neuromodulation, active implantables, orthopedics, enabling technologies, surgical visualization technologies, urology and women’s health.  She has had a keen focus on sensor technologies, digital biomarkers and personalized or predictive technologies.  She advises investment funds, corporates and scaling start-ups on a broad range of health technologies and opportunities.  Sabeen also advises various international governments on their future medical technology growth planning, innovation ecosystems and infrastructure, policies, as well as import and export technology opportunities.  Her understanding of macro planning and population health needs helps add insight into the future planning of technologies at the granular levels.

Sabeen’s global experiences include having lived abroad in Australasia for ten years, allowing her insights into a number other healthcare systems and the nuanced market needs of other ecosystems.  These deep learnings allow her to seamlessly translate opportunities and refine strategies based on market intelligence and customer needs. 

Sabeen speaks passionately on national and international stages on various topics that are nascent to investors and companies, and is a noted global thought leader within healthcare on various topics. 

Sabeen studied in the USA for her undergraduate degree in Biology and continued further executive education with the INSEAD Business School in France. 

Partner, MedTech Practice


Evelyn is a partner based out of Washington D.C., with almost 20 years of experience, working with executives and C-suites in global MedTech, investor, and pharmaceuticals companies. Evelyn leverages her deep expertise across multiple focus areas including cardiovascular, acute care, renal care, surgical and revascularization procedures, to help her clients solve some of their toughest business challenges. She works with a range of clientele from the largest conglomerates to up-and-coming smaller companies. Most recently in 2023, she was recognized by Consulting Magazine as one of the most influential consultants globally, winning the 2023 Top Consulting Award in Client Service.

 Prior to LSC, Evelyn held leadership roles in strategy consulting companies including Boston Consulting Group, EY-Parthenon and the boutique healthcare consulting firm Kx Advisors. She also served on the Board of the World Bank in Washington D.C. as an advisor. Evelyn is passionate about mentoring and coaching women in the business place and has founded women’s business initiatives. She holds an MBA with a double major in Operations and Marketing from Wharton School at the University of Pennsylvania and is a Joseph Wharton Fellow for outstanding leadership.  She graduated with a BA with special awards and triple majored in Mathematical Methods in Social Sciences, Economics, and International Studies from Northwestern University.

partner, Investors Practice

Fabio LottoMILAN, ITALY.

Fabio brings 20 years of management consulting experience with Bain&Co and OC&C among others. He held leadership positions with responsibility over Italy and Eastern Europe and as team lead of the Private Equity Group of Bain. 

Fabio is an expert in corporate strategy, top-line growth, portfolio optimization, international expansion, commercial excellence, e-commerce acceleration, route-to-market strategy, sales force organization, turnaround. He developed extensive experience in due diligence and post-acquisition value enhancement projects for portfolio companies owned by PE and VC investors. He has also worked on a broad range of corporate mergers & acquisitions and PMI in several industries. 

Fabio has relevant international experience in working and living for several years in Russia, US and UK. He earned a MBA at SDA Bocconi Milano which included an exchange at NYU Stern Business School in NY (USA) and a degree in Business Administration at the University of Pisa. He has been a Student of Business Administration at “Scuola Superiore Sant’Anna di Pisa”. He also participated in executive education programs on digital marketing and Analytics Powered Strategy at Columbia University (NY) and Kellogg School of Management at Northwestern University (Boston).